Status of Topotecan in Small-Cell Lung Cancer

Publisher： Karger

E-ISSN： 2296-5262|23|3|1-1

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.23, Iss.3, 2000-05, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Topotecan (Hycamtin®) in the Therapy of Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1999-01 ,pp. : 13-17

Karger

Access to resources Recommend Favorite

Topotecan in the First-Line Treatment of Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 3, 2000-05 ,pp. : 13-17

Karger

Access to resources Recommend Favorite

Topotecan/Taxol in First-Line Small-Cell Lung Cancer: Where Is the Benefit?

By  

Oncology Research and Treatment, Vol. 23, Iss. 3, 2000-05 ,pp. : 7-8

Karger

Access to resources Recommend Favorite

Feasibility of Oral Topotecan in Previously Untreated Patients with Small-Cell Lung Cancer Ineligible for Standard Therapy

By  

Oncology, Vol. 61, Iss. 1, 2001-09 ,pp. : 42-46

Karger

Access to resources Recommend Favorite

A Phase I Trial of a 5-Day Schedule of Intravenous Topotecan and Etoposide in Previously Untreated Patients with Small-Cell Lung Cancer

By  

Oncology, Vol. 61, Iss. 1, 2001-09 ,pp. : 25-29

Karger

Access to resources Recommend Favorite